HALOZYME THERAPEUTICS, INC. (HALO) Current Reports & Earnings Releases
Upcoming
- 2026-11-02 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-18 | 8-K | Officer / Director Changes | SEC |
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-02 | 8-K | Officer / Director Changes | SEC |
| 2026-05-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Shareholder Vote Results | SEC |
| 2026-04-30 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-04-24 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-03-12 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-02-17 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-28 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-09 | 8-K | Officer / Director Changes | SEC |
| 2025-12-08 | 8-K | Officer / Director Changes | SEC |
| 2025-11-24 | 8-K | Officer / Director Changes | SEC |
| 2025-11-12 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-11-07 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Material Agreement, Direct Financial Obligation, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-03 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-10-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-06 | 8-K | Officer / Director Changes | SEC |
| 2025-10-03 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-10-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-02 | 8-K | Shareholder Vote Results | SEC |
| 2025-03-21 | 8-K | Officer / Director Changes | SEC |
| 2025-02-18 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-13 | 8-K | Officer / Director Changes | SEC |
| 2025-01-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-26 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-02-20 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-17 | 8-K | Results of Operations | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.